Here are four notes:
1. LDR has a market cap of $503.95 million.
2. The company’s stock has declined 58.1 percent since July 10, 2015, and it continues to trend down.
3. It has underperformed the S&P500 by 47.9 percent.
4. Out of 10 analysts covering LDR, 11 rate it “buy,” zero “sell,” while one rates it “hold.”
More articles on devices:
43 spine, orthopedic devices receive FDA 510(k) clearance in January
Foot and ankle market to reach $5.4B in 2020 — 4 insights
Wright Medical Group shares receive average price target of $28.11: 5 things to know
